Larimar Therapeutics (LRMR) Enterprise Value (2014 - 2026)
Larimar Therapeutics' Enterprise Value was $160.58 million in Q2 2026, up 245.2% from $46.52 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Enterprise Value (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Larimar Therapeutics' Enterprise Value was -$290.24 million through Jun 30, 2026; for FY2025, it came in at $179.72 million, up 183.0% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $63.51 million in FY2024 (-43.8%), $113 million in FY2023, -$12.03 million in FY2022 and $121 million in FY2021 (-25.2%).
- Quarterly Enterprise Value has moved between -$53.57 million (Q3 2022) and $256.95 million (Q1 2024) over five years.
- Compared with a year earlier, Enterprise Value was higher in three of the last six quarters, with growth averaging 71.1%.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2023 (growth of 822.0%); the worst was Q1 2022 (a decline of 93.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.58 Mn |
| Dec 31, 2025 | 179.72 Mn |
| Sep 30, 2025 | 101.02 Mn |
| Jun 30, 2025 | 46.52 Mn |
| Mar 31, 2025 | -19.87 Mn |
| Dec 31, 2024 | 63.51 Mn |
| Sep 30, 2024 | 214.23 Mn |
| Jun 30, 2024 | 236.50 Mn |
| Mar 31, 2024 | 256.95 Mn |
| Dec 31, 2023 | 113.00 Mn |
| Sep 30, 2023 | 77.84 Mn |
| Jun 30, 2023 | 31.23 Mn |
| Mar 31, 2023 | 84.49 Mn |
| Dec 31, 2022 | -12.03 Mn |
| Sep 30, 2022 | -53.57 Mn |
| Jun 30, 2022 | -20.21 Mn |
| Mar 31, 2022 | 9.16 Mn |
| Dec 31, 2021 | 121.00 Mn |
| Sep 30, 2021 | 126.18 Mn |
| Jun 30, 2021 | 80.28 Mn |
API Access
Larimar Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();